A Drug Already Proven Safe in Humans Just Reduced Multiple Signs of Alzheimer's in Mice
A drug previously proven safe for humans has demonstrated the ability to reduce multiple signs of Alzheimer's disease in mouse models.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
KCL-286, a drug originally intended for spinal cord injuries, has shown promise in a preclinical study. The treatment slowed Alzheimer's disease in mice by targeting multiple pathways and DNA damage.
Coverage from ScienceAlert, Futurity, and Drug Target Review emphasizes the drug's existing safety record in humans and its multi-pathway approach. Technology Networks and WebWire further highlight its application in treating DNA damage associated with the disease.
Future developments depend on whether this investigational drug can translate these preclinical mouse results into effective treatments for human Alzheimer's patients.
Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 7m ago.
Quick answers
What is the name of the drug?
The drug is identified as KCL-286.
What was the drug originally developed for?
According to coverage, it is a spinal cord injury drug.
In what subjects was the Alzheimer's reduction observed?
The reduction of signs of Alzheimer's was observed in mice during a preclinical study.
Coverage (5)
- Spinal Cord Injury Drug Shows Promise for Alzheimer’s Disease Technology Networks · 9h ago
- KCL-286 targets multiple Alzheimer’s pathways in preclinical study Drug Target Review · 9h ago
- New drug slows Alzheimer’s disease in mice Futurity · 9h ago
- Could an investigational drug that targets DNA damage help treat Alzheimer’s disease? WebWire · 9h ago
- A Drug Already Proven Safe in Humans Just Reduced Multiple Signs of Alzheimer's in Mice ScienceAlert · 9h ago
Topics
From around our network
- New Guidelines Issued for Alzheimer’s Disease Diagnosis and Detection newsdirectory3.com
Related trends
Scientists Discover a Sign of Dementia up to 15 Years Before Diagnosis
Researchers have identified indicators of dementia and Alzheimer's disease that may appear up to 15 years before a formal diagnosis.
Alzheimer's: BCG vaccine may reshape brain immune response
New clinical trial data suggests the tuberculosis BCG vaccine may reduce Alzheimer's risk by remodeling the brain's immune environment.
I said yes to an Alzheimer’s blood test. Then I panicked.
New blood tests using circular RNAs and protein markers are enabling the detection of Alzheimer's risk decades before symptoms appear.
EXCLUSIVE: Danny Glover Reveals Alzheimer’s Diagnosis and Shares Update on Illness
Danny Glover's public revelation of his Alzheimer’s diagnosis has sparked widespread media coverage and public support.
Scientists may have finally found how Alzheimer's spreads through the brain
Researchers may have identified a key mechanism in the spread of Alzheimer's disease through the brain.
One Specific Blood Protein Can Identify Dementia Risk Decades Before Diagnosis
New blood-based protein tests are enabling the detection of Alzheimer's and dementia risk decades before clinical symptoms appear.